lufotrelvir: Clinical Trials

3 trials of lufotrelvir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow lufotrelvir: new trials by email Literature Review of lufotrelvir trials Research Report on lufotrelvir

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants
PF-07304814 - Healthy
Phase 1CompletedPfizer52021-10-072025-10-20
Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants
PF-07304814, Placebo - Healthy
Phase 1CompletedPfizer162020-10-232021-01-06
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.
PF-07304814, Placebo - Viral Disease
Phase 1CompletedPfizer262020-09-092023-05-03

Conditions studied

COVID-19 (2)  ·  Virus Diseases (2)

Sponsors

Pfizer (3)

Countries

United States (3)  ·  Belgium (1)  ·  Brazil (1)  ·  Spain (1)

Results publications

PMID 34541899, PMID 36285536, PMID 37559753